CWM
FLGT icon

CarsonAllaria Wealth Management’s Fulgent Genetics FLGT Stock Holding History

CarsonAllaria Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-93
Closed -$3.44K – 379
2023
Q2 		$3.44K Hold
93
– – ﹤0.01% 289
2023
Q1 		$2.9K Hold
93
– – ﹤0.01% 285
2022
Q4 		$3K Hold
93
– – ﹤0.01% 263
2022
Q3 		$4K Hold
93
– – ﹤0.01% 238
2022
Q2 		$5K Hold
93
– – ﹤0.01% 230
2022
Q1 		$6K Hold
93
– – 0.01% 230
2021
Q4 		$9K Buy
+93
New +$8.17K 0.01% 212

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CarsonAllaria Wealth Management's FLGT Position: Q3 2023 in Review

CarsonAllaria Wealth Management sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 93 shares — an estimated $3.44K sold.

CarsonAllaria Wealth Management first reported a position in FLGT in Q4 2021 and held it in 7 quarters. The position peaked at $9K in Q4 2021. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

  • CarsonAllaria Wealth Management reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 93 Fulgent Genetics shares in Q3 2023, an estimated $3.44K.
  • CarsonAllaria Wealth Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 7 quarters.
  • CarsonAllaria Wealth Management's Fulgent Genetics position peaked at $9K in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2023, filed 9 Nov 2023.